ultra-wide-field fluorescein angiography per oral administration

ultra-wide-field fluorescein angiography per oral administration - UWS-FA per oral

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011040

Enrollment

Registered

2014-06-01

Start date

2013-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy, retinal vain occulusion, uveites

Interventions

PO-FA using UWF system and evaluate whether this method contribute to safety FA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diabetic retinopathy, retinal vein occlusion and uveites are recruited.

Exclusion criteria

Exclusion criteria: patients who have history of fluorescein allergy, liver function failure, abnormal hypertension, cerebral vascular disorder, pregnant and minority.

Design outcomes

Primary

Measure	Time frame
Ratio of complication Patient"s stress	—

Countries

Japan

Contacts

Public ContactMasahiko Sugimoto

Mie University, School of Medicine Department of Ophthalmology

sugmochi@clin.medic.mie-u.ac.jp0592315027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026